Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.
about
Evolution of cooperation among tumor cellsThe Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal MetastasisMicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancerInsidious changes in stromal matrix fuel cancer progressionTransient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-Beta mediated mechanism in a mouse xenograft model of breast cancerBiomimetic tumor microenvironment on a microfluidic platformQuantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array dataFunctions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targetingParadoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell lineA stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agentsDifferences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinomaA novel asymmetric 3D in-vitro assay for the study of tumor cell invasion.Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practiceHuman uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture.Sunitinib mesylate inhibits proliferation of human colonic stromal fibroblasts in vitro and in vivo.Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells.Fibroblast phenotypes in different lung diseases.CD99 is a novel prognostic stromal marker in non-small cell lung cancer.Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteinsBiological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancerThe effect of 1,25 dihydroxyvitamin D3 treatment on the mRNA levels of β catenin target genes in mice with colonic inactivation of both APC alleles.In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment.GSTPi-positive tumour microenvironment-associated fibroblasts are significantly associated with GSTPi-negative cancer cells in paired cases of primary invasive breast cancer and axillary lymph node metastases.Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissueThe Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow.The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cellsFibroblast surface-associated FGF-2 promotes contact-dependent colorectal cancer cell migration and invasion through FGFR-SRC signaling and integrin αvβ5-mediated adhesionActivated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.The stroma-a key regulator in prostate function and malignancyParacrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.Stroma-directed molecular targeted therapy in gastric cancer.Organotypic modelling as a means of investigating epithelial-stromal interactions during tumourigenesis.Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells.Inflammation and EMT: an alliance towards organ fibrosis and cancer progression.Molecular biology of breast tumor progression: a view from the other side.Directed migration of mesenchymal cells: where signaling and the cytoskeleton meet.Immune Therapy in GI Malignancies: A Review.
P2860
Q24671009-71767BB5-B22D-4472-8150-5EDE13864559Q26783022-7740616C-4B3F-4590-A74A-CD4017653AE2Q26849525-061A2BD7-2DD5-4CBB-8318-8DDD41DDA88FQ26851261-1A0D5BD9-A9F4-41C0-831F-9D88347DF0D0Q27332206-9EB329AF-49FE-458F-9223-173900A85F1EQ28485304-9B0DFF18-240B-4031-9EFA-FFC804879A03Q28752458-40190BCD-5EB1-465C-A038-1D32AA34A7DCQ28755868-22892B43-B39C-4EBD-9896-2F1D0C69DE13Q33301048-A5B0EAD5-F40E-4379-B487-7C13E3379F86Q33330767-45EC639D-9542-4D29-816D-C6C874534287Q33498941-85D4D502-B623-4B90-AE21-EAAC7D409CBCQ33516890-6A51C04B-5A4A-4F21-9111-CD71DC4D7320Q33523432-6056FE56-E1F9-4823-936F-FB9734133516Q33738887-EF47C7CC-C6ED-46B0-8995-C9ED5A528043Q33759960-665EEB29-9557-43D3-9E14-DA89B0794EF1Q33964731-76FC3F13-BFD7-42AC-80FD-532C2159EE91Q34029444-686852E5-7878-4072-9B1B-B262BB1472EAQ34034676-6BE059E0-4942-434D-BA13-27ED9C9D8B64Q34235010-1BA1E34F-4B36-4717-88A1-C2C521B7AA7EQ34258877-6798347B-9EAF-451F-99C0-3C92BE5F5B7EQ34460058-ED467325-7C91-45C3-83B8-8E4E0447D942Q34663710-ED0AC344-42D9-455A-9B1D-A7ED08066184Q35181226-E7CF9D5C-8E61-4B8E-BA00-94123E3B2AADQ35216502-64B208AD-5925-4857-B036-EFF814606DD4Q35527125-C9F4D2BB-F452-4595-81AC-52D0A5149676Q35767934-12423592-D98E-43E4-9BCB-2C3EB93106CAQ35810653-09FD60CA-5BB3-4E69-ACB3-82FD1B308232Q35931795-BF8F65C4-8558-4704-AE99-A48AB11DC993Q35987339-32EC6A94-25AA-4239-B7BB-BF0037547491Q36866472-8AED10B2-3D35-4B07-BA16-5A24E6612349Q37017028-380B92DB-4FAA-4411-A749-B7F12D737412Q37036301-5C8ED169-F33C-49BE-8532-0EECB6A8F3F2Q37148199-B7FB62F6-78A2-4143-8F81-4A9068298302Q37348888-B43156E8-C9D8-4067-992C-DE16F2DF3D7BQ37549396-1E77B2CD-9892-4E20-9906-30242E95E9DBQ37589853-D30E2669-42DA-45A7-8633-C5BD56E5574DQ37668231-0694512B-48EF-425F-A230-A66A4B53E11CQ37756399-E454CE5C-C2D7-4A7E-93D8-1C0E1350ACE5Q38226851-448C95B7-49F1-4724-8C50-CBD0D53881C3Q38445709-94AB2E6F-A39D-4EDC-B23A-5145F90D7F1C
P2860
Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Exploring the tumour environme ...... as targets in cancer therapy.
@ast
Exploring the tumour environme ...... as targets in cancer therapy.
@en
type
label
Exploring the tumour environme ...... as targets in cancer therapy.
@ast
Exploring the tumour environme ...... as targets in cancer therapy.
@en
prefLabel
Exploring the tumour environme ...... as targets in cancer therapy.
@ast
Exploring the tumour environme ...... as targets in cancer therapy.
@en
P2860
P1476
Exploring the tumour environme ...... as targets in cancer therapy.
@en
P2093
Arne Ostman
Patrick Micke
P2860
P304
P356
10.1517/14728222.9.6.1217
P407
P577
2005-12-01T00:00:00Z